[Translated article] Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage

• Asıl Yazarlar: B. Navarro Matilla (Yazar), P.L. Ortiz Romero (Yazar), R.M. Pujol Vallverdú (Yazar), A. Combalia Escudero (Yazar), I. Zapata Paz (Yazar), E. González Barca (Yazar), C. Muniesa Montserrat (Yazar), M. Morillo Andújar (Yazar), A. Pérez Ferriols (Yazar), C. Román Curto (Yazar), R. Fernández de Misa Cabrera (Yazar), M. Hospital Gil (Yazar), A. Marín Niebla (Yazar), P.J. Rios Rull (Yazar), F. de la Cruz Vicente (Yazar), R.M. Izu Belloso (Yazar), A. Martín García-Sancho (Yazar), M.E. Parera Amer (Yazar), R. Córdoba Mascuñano (Yazar), M.D. Ramón Quiles (Yazar), A. Saus Carreres (Yazar), R. del Campo García (Yazar), S. Machan (Yazar), P. Viguera Ester (Yazar), J. Blanco Garnelo (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2024-02-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background and objective: The cost of treating cutaneous T-cell lymphoma (CTCL) in Spain is unknown. With the advent of new treatments, it is more important than ever to gain an accurate picture of the true costs involved. The MICADOS study had 2 primary objectives: 1) to evaluate the impact of CTCL...